Date:
Wed, 05 Aug 2026 13:18:04 EDT
Content:
The U.S. Food and Drug Administration (FDA) has released a regulatory update concerning MSN Life Sciences Private Limited, Unit II. The update follows an inspection of the company’s manufacturing facility located in Telangana, India.
The inspection at the Chandampet site was conducted on September 13, 2024. As part of its international oversight, the FDA monitors these facilities to ensure that pharmaceutical products manufactured abroad meet the rigorous safety and quality standards required for the United States market.
This report identifies the facility under registration number 3011543392. Such updates are essential for maintaining transparency regarding the compliance status of global life sciences manufacturers and their production units.
Source: U.S. Food and Drug Administration
Link:
http://www.fda.gov/about-fda/msn-life-sciences-private-limited-unit-ii
Keywords:
FDA, MSN Life Sciences, Pharmaceutical Inspection, India, Manufacturing Compliance